Africa accounted for 90% of all malaria cases worldwide in 1994, and the pandemic is tightening its grip on the continent, especially in the sub-Saharan region.
Experts who recently met at Abidjan, the Ivory Coast seaport city, sounded the alarm at a national seminar on malaria, noting that last year 3 million people, double the figure of the previous year, came down with the disease.
Statistics show that 10 years ago around 30% of all fever cases among African children were caused by malaria. However, by 1992 that figure had soared to 60%. The experts attributed the sharp rise to inadequate preventative measures and little progress in medical research.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze